Cargando…

Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis

Detalles Bibliográficos
Autores principales:	Hsu, Chi-Kuei, Chao, Chien-Ming, Lai, Chih-Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359495/ https://www.ncbi.nlm.nih.gov/pubmed/35995666 http://dx.doi.org/10.1016/j.jmii.2022.08.002

Ejemplares similares

Different effect of inhaled and systemic corticosteroids on the outcome of COVID-19 among patients with asthma
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Clinical benefits of inhaled ciclesonide for hospitalized patients with COVID-19 infection: a retrospective study
por: Kuo, Kuan-Chih, et al.
Publicado: (2022)

Is there a role for inhaled ciclesonide in the treatment of COVID-19?
por: Salvi, Sundeep Santosh
Publicado: (2021)

The association between immunosuppressant and the outcome of COVID-19
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial
por: Ezer, Nicole, et al.
Publicado: (2021)

Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)
por: Duvignaud, Alexandre, et al.
Publicado: (2022)

Therapeutic potential of ciclesonide inhalation for COVID-19 pneumonia: Report of three cases
por: Iwabuchi, Keisuke, et al.
Publicado: (2020)

From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids
por: Nave, Ruediger, et al.
Publicado: (2013)

Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma
por: Schaffner, Timothy J, et al.
Publicado: (2009)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006)

The efficacy and safety of inhaled corticosteroids: are we ignoring the potential advantages of ciclesonide?
por: van der Molen, Thys, et al.
Publicado: (2014)

Clinical efficacy and safety of Janus kinase inhibitors for COVID-19: A systematic review and meta-analysis of randomized controlled trials
por: Chen, Ching-Yi, et al.
Publicado: (2021)

Inhaled ciclesonide in adults hospitalised with COVID-19: a randomised controlled open-label trial (HALT COVID-19)
por: Brodin, Daniel, et al.
Publicado: (2023)

The clinical efficacy and safety of mesenchymal stromal cells for patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
por: Chen, Ching-Yi, et al.
Publicado: (2022)

Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial
por: Song, Joon-Young, et al.
Publicado: (2021)

Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection
por: Zamanian, Roham T., et al.
Publicado: (2020)

COVID-19 associated with concomitant mucormycosis and aspergillosis
por: Lai, Chih-Cheng, et al.
Publicado: (2022)

Ciclesonide for the treatment of asthma
por: Dahl, Ronald
Publicado: (2006)

A randomized clinical trial on inhaled ciclesonide for managing acute asthma in the emergency room
por: Martins, Demétrius Tierno, et al.
Publicado: (2022)

Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids
por: Postma, Dirkje S., et al.
Publicado: (2017)

Inhaled corticosteroids for outpatients with COVID-19: a meta-analysis
por: Lee, Todd C., et al.
Publicado: (2022)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

The Role of Eosinophils during the Withdrawal of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2021)

Aminoglycoside inhalational therapy: a potential pitfall of antimicrobial stewardship in outpatient settings
por: Kusama, Yoshiki, et al.
Publicado: (2020)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

A mysterious surge of aspergillosis among non-SARS-CoV-2 patients during COVID-19 pandemic
por: Lai, Chih-Cheng, et al.
Publicado: (2021)

Similar Results in Children with Asthma for Steady State Pharmacokinetic Parameters of Ciclesonide Inhaled with or without Spacer
por: Boss, H., et al.
Publicado: (2010)

Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008)

The impact of inhaled corticosteroid on SARS-CoV2 infection
por: Lai, Chih-Cheng
Publicado: (2021)

Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa
por: Sato, Hideyuki, et al.
Publicado: (2007)

Treatment of COVID-19 by Inhaled NO to Reduce Shunt?
por: Hedenstierna, Göran, et al.
Publicado: (2020)

Inhaled budesonide for early treatment of COVID-19
por: Choi, Jae Chol, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: San-Juan, Rafael, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: Zeitlinger, Markus, et al.
Publicado: (2021)

Profile of ciclesonide for the maintenance treatment of asthma
por: Singas, Effie, et al.
Publicado: (2011)

Seroconversion in household members of COVID-19 outpatients
por: Cox, Rebecca J, et al.
Publicado: (2021)

Reply to Lipworth et al.: Inhaled Corticosteroids and COVID-19
por: Maes, Tania, et al.
Publicado: (2020)

Inhaled budesonide for early treatment of COVID-19 – Authors' reply
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Coronataxi Brings Outpatient Care to COVID-19 Patients
por: Hippchen, Theresa, et al.
Publicado: (2020)

Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients
por: Zayet, Souheil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a0a03dssc30c3n69f3ll6j5c27